Search the Newsreel

JPMorgan values the New York Knicks at $11.75 billion following bombshell Lakers deal

The New York Knicks may be this year's NBA champions, but the team's valuation is still a touch short in the wake of the bombshell deal for the Los Angeles Lakers. At least, according to the number-crunchers at JPMorgan (JPM). Analyst David Karnovsky slapped …

JPMorgan Chase & Co. Downgrades Cinemark (NYSE:CNK) to Neutral

JPMorgan Chase & Co. downgraded Cinemark (NYSE:CNK) from an "overweight" to a "neutral" rating, setting a $39 price target. Despite the downgrade, Cinemark maintains an overall "Moderate Buy" consensus rating from analysts, with an average price target of $37.93. The company recently surpassed quarterly …

JPMorgan Reveals Bitcoin, Ethereum, and XRP ETF Holdings in Q2 Filing

JPMorgan's Q2 2026 filing with the U.S. SEC reveals a significant increase in its cryptocurrency ETF holdings, including a sharp rise in Bitcoin exposure and a 338% jump in Ethereum ETF holdings. The bank also re-entered the XRP market through two ETF positions and …

JPMorgan Reportedly Dropped Polymarket As Banking Client Over Regulatory Concerns— But Still Eyes IPO Rol

JPMorgan reportedly ended its banking relationship with prediction market platform Polymarket in October over regulatory concerns, despite still showing interest in an underwriting role should Polymarket pursue an IPO. This move highlights the difficulties emerging companies face in securing banking services within the rapidly …

Ticino Wealth Increases Stake in JPMorgan Chase & Co. $JPM

Nexus Investment Management ULC Has $59.04 Million Stock Holdings in JPMorgan Chase & Co. $JPM

JPMorgan Chase & Co. $JPM Shares Sold by Moody Lynn Lieberson & Walker LLC

JPMorgan Chase & Co. Lowers ITV (LON:ITV) Price Target to GBX 82

JPMorgan Chase & Co. has reduced its price target for ITV (LON:ITV) from GBX 85 to GBX 82, maintaining a "neutral" rating on the broadcaster's stock. This new target suggests a potential upside of 15.49% from ITV's last closing price. Despite the lowered target …

Thomasville National Bank Invests $33.27 Million in JPMorgan Chase & Co. $JPM

JPMorgan Chase & Co. $JPM Shares Acquired by Merit Financial Group LLC

JPMorgan Adjusts PT on Essex Property Trust to $295 From $275, Maintains Underweight Rating

JPMorgan has increased its price target for Essex Property Trust (ESS) to $295 from $275, while maintaining an "Underweight" rating on the stock. This adjustment comes amidst other recent analyst price target changes for Essex Property Trust, with some analysts maintaining neutral or hold …

JPMorgan Debanked Polymarket Over Regulatory Concern, FT Says

(Bloomberg) -- JPMorgan Chase & Co. terminated its banking relationship with Polymarket last year over regulatory concerns, the Financial Times reported. Most Read from Bloomberg Selena Gomez Accused of Fraud by Mental-Health Startup Investors Costliest US Bond Sale Since 2001 Is Investor Warning to …

Oracle im JPMorgan-Fokus: US-Bank senkt Schätzungen für operativen Gewinn 2027/2028

Clarity Financial LLC Boosts Stock Holdings in JPMorgan Chase & Co. $JPM

JPMorgan debanks Polymarket on regulatory issues - report (JPM:NYSE)

JPMorgan Chase (JPM) has reportedly debanked Polymarket, the world's largest prediction market platform, due to regulatory concerns. Polymarket was informed last October to seek a new banking partner. The Financial Times reported this development, citing unidentified sources.

JPMorgan Cuts Polymarket Banking Ties as Regulatory Risks Persist

JPMorgan Chase severed its banking relationship with prediction market Polymarket in October 2025 due to regulatory concerns, forcing Polymarket to find a new bank. This decision highlights the ongoing challenges digital asset and prediction market firms face in securing banking services, despite Polymarket's efforts …

JPMorgan debanked Polymarket over regulatory concerns

JPMorgan Chase terminated its banking relationship with Polymarket last year over regulatory concerns, underscoring enduring cautious PREMIUM Upgrade to read this Financial Times article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already …

Is JPMorgan Chase (JPM) Undervalued Following Its Latest Long Term Funding Moves?

JPMorgan Chase (JPM) recently issued new callable notes with maturities up to 2056, providing insight into its long-term funding. Despite strong share price momentum and being only slightly below analyst targets, Simply Wall St's narrative suggests JPM is 2.3% undervalued, with a fair value …

JPMorgan Chase (JPM) Stock Looks Reasonable On A 166% Five Year Run

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. JPMorgan Chase stock has delivered a strong 166.0% total return over the past 5 …

JPMorgan Says the AI Threat to Salesforce Is Overblown

JPMorgan initiated coverage on Salesforce (NYSE:CRM) with an Overweight rating and a $250 price target, stating that concerns about AI disruption and competitive dynamics are "overblown." Analyst Samik Chatterjee anticipates a pickup in core business growth and believes the market has already factored in …

JPMorgan Says Salesforce Investors Miss Bigger Story

This article first appeared on GuruFocus. JPMorgan is turning bullish on Salesforce (NYSE:CRM), arguing that investors have pushed concerns about artificial intelligence and slowing growth too far. The bank initiated coverage of Salesforce with an Overweight rating and a December 2027 price target of …

JPMorgan Just Upgraded Salesforce Stock. Here's Why.

JPMorgan upgraded Salesforce (CRM) stock to "Overweight" with a $250 price target, citing its attractive valuation at less than 4x sales, which the analyst believes is overly punitive. The upgrade comes despite the stock being down over 20% year-to-date, with JPMorgan analyst Samik Chatterjee …

JPMorgan Chase & Co. Cuts Chemours (NYSE:CC) Price Target to $15.00

JPMorgan Chase & Co. has lowered its price target for Chemours (NYSE:CC) from $22.00 to $15.00, while maintaining a "neutral" rating, indicating a slight downside from its current price. This adjustment follows Chemours missing its quarterly EPS and revenue estimates. Analyst sentiment for Chemours …

JPMorgan Chase & Co. Raises Cytokinetics (NASDAQ:CYTK) Price Target to $103.00

JPMorgan Chase & Co. has increased its price target for Cytokinetics (NASDAQ:CYTK) to $103.00 from $97.00, reiterating an "overweight" rating and suggesting a 37.04% upside. This comes as Cytokinetics shares dipped slightly despite the company surpassing EPS and revenue expectations. Analyst sentiment remains largely …

JPMorgan Chase & Co. (JPM) Up 5.3% Since Last Earnings Report: Can It Continue?

A month has gone by since the last earnings report for JPMorgan Chase & Co. (JPM). Shares have added about 5.3% in that time frame, outperforming the S&P 500. But investors have to be wondering, will the recent positive trend continue leading up to …

JPM6481659 Bond Yield and Price — FINRA:JPM6481659

This article provides detailed information about the JPMorgan Chase & Co. 6.0% 14-AUG-2041 bond (JPM6481659 FINRA). It covers key terms such as outstanding amount, face value, coupon rate, and maturity date, along with issuer details like sector, industry, and ISIN. The company profile for …

JPMorgan, Goldman, Invesco Test Blockchain Across Wall Street

JPMorgan, Goldman Sachs, Invesco, and Citadel Securities, along with nearly 40 other firms, conducted a four-hour test in July to assess the viability of tokenized assets on blockchain networks. Overseen by the DTCC, the exercise involved trading stocks and Treasuries, posting collateral, and meeting …

JPMorgan initiates Salesforce stock coverage with overweight rating

JPMorgan has initiated coverage on Salesforce (NYSE:CRM) with an overweight rating and a $250 price target, set for December 2027. The firm anticipates an acceleration in Salesforce's core business in the second half of fiscal 2027 and believes current valuation is inexpensive, pricing in …

JPMorgan gets bullish on Salesforce, says concerns are "overblown"

Investing.com -- JPMorgan initiated Salesforce (CRM) at Overweight, saying concerns weighing on the stock are "overblown" and that the shares are pricing in further deceleration rather than progress toward the company's Rule of 50 target. Analyst Samik Chatterjee moved CRM to an Overweight rating …

JPMorgan Chase & Co. $JPM is Prevail Innovative Wealth Advisors LLC's 9th Largest Position

Prevail Innovative Wealth Advisors LLC increased its stake in JPMorgan Chase & Co. (NYSE:JPM) by 33.5% in the second quarter, making it their 9th largest position. Several other institutional investors also modified their holdings in JPM. The article also covers JPM's stock performance, dividend …

JPMorgan Upgrades Akamai Technologies to Neutral From Underweight, Adjusts PT to $158 From $132

JPMorgan has upgraded Akamai Technologies (AKAM) to Neutral from Underweight, raising its price target to $158 from $132. This upgrade reflects a more positive outlook for the company. The article also lists several other recent analyst adjustments for Akamai, displaying varying price target changes …

JPMorgan’s Nio Position Shrinks 79% From Late-2025 High

JPMorgan significantly reduced its stake in Chinese automaker Nio, selling nearly 3.9 million shares in Q2 2026, marking a 59% cut from its Q1 position and an overall 78.8% reduction from its late-2025 peak. This aggressive liquidation follows a period of extreme volatility in …

Die JPMorgan-Chase-Aktie legt nach Rekordquartal und optimistischem Marktblick zu

JPMorgan Chase & Co. (NYSE:JPM) Given Consensus Recommendation of "Moderate Buy" by Analysts

JPMorgan Chase & Co. (NYSE:JPM) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $359.33. The stock opened near its 12-month high of $366.09, and institutional investors own a significant 71.55% of the company. Despite insider sales …

SLS Stock Logs Best Day In Over A Week: JPMorgan Buys In And Stifel Boosts Bet Ahead Of Key AML Data

Shares of Sellas Life Sciences (SLS) saw their best day in over a week after JPMorgan Chase disclosed a new stake and Stifel Financial increased its holdings. Alliance Global also raised its price target for SLS to $35 from $25, citing the potential of …

REG - Trainline PLC JPMorgan Chase & Co - Holding(s) in Company

JPMorgan Chase & Co. has notified Trainline PLC of a change in its major holdings, crossing a threshold on August 10, 2026, and notifying the issuer on August 12, 2026. The financial institution now holds a total of 5.143391% of voting rights, combining direct …